Natco Pharma Q3 Results: Net profit declines 38% to ₹132.4 crore, dividend declared

NATCO Pharma reported a 37.75% decline in Q3 FY2025 net profit, dropping to ₹132.4 crore due to a downturn in formulation exports. Consolidated revenue fell to ₹474.8 crore, with EBITDA down 85.5%, reflecting significant operational challenges.

source https://www.livemint.com/market/stock-market-news/natco-pharma-q3-results-net-profit-declines-38-to-rs-132-4-crore-dividend-declared-11739170404580.html